R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi | Zendy

Massimo Federico | Zendy; Stefano Luminari | Zendy; Alessandra Dondi | Zendy; Alessandra Tucci | Zendy; Umberto Vitolo | Zendy; Luigi Rigacci | Zendy; Francesco Di Raimondo | Zendy; Angelo Michele Carella | Zendy; Alessandro Pulsoni | Zendy; Francesco Merli | Zendy; Luca Arcaini | Zendy; F. Angrilli | Zendy; Caterina Stelitano | Zendy; Gianluca Gaïdano | Zendy; Matteo Dell’Olio | Zendy; Luigi Marcheselli | Zendy; Vito Franco | Zendy; Sara Galimberti | Zendy; Stefano Sacchi | Zendy; Maura Brugiatelli | Zendy

Open Access

R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi

Author(s) -

Massimo Federico,

Stefano Luminari,

Alessandra Dondi,

Alessandra Tucci,

Umberto Vitolo,

Luigi Rigacci,

Francesco Di Raimondo,

Angelo Michele Carella,

Alessandro Pulsoni,

Francesco Merli,

Luca Arcaini,

F. Angrilli,

Caterina Stelitano,

Gianluca Gaïdano,

Matteo Dell’Olio,

Luigi Marcheselli,

Vito Franco,

Sara Galimberti,

Stefano Sacchi,

Maura Brugiatelli

Publication year - 2013

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2012.45.0866

Subject(s) - medicine , follicular lymphoma , stage (stratigraphy) , chop , oncology , randomized controlled trial , lymphoma , gynecology , paleontology , biology

Although rituximab (R) is commonly used for patients with advanced follicular lymphoma (FL) requiring treatment, the optimal associated chemotherapy regimen has yet to be clarified.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research